Skip to main content

Recombinant Human 6-Phosphogluconate Dehydrogenase/PGD, CF

R&D Systems, part of Bio-Techne | Catalog # 8964-DH

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
8964-DH-020

Key Product Details

Source

E. coli

Accession #

Conjugate

Unconjugated

Applications

Enzyme Activity

Product Specifications

Source

E. coli-derived human 6-Phosphogluconate Dehydrogenase/PGD protein
Ala2-Ala483, with a N-terminal Met and 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met

Predicted Molecular Mass

54 kDa

SDS-PAGE

48 kDa, reducing conditions

Activity

Measured by its ability to dehydrogenate 6-phosphogluconic acid.
The specific activity is >6000 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation and Storage

8964-DH
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl, TCEP and Glycerol.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: 6-Phosphogluconate Dehydrogenase/PGD

6-phosphogluconate dehydrogenase (PGD) is the second dehydrogenase in the pentose phosphate pathway (1). It catalyzes the oxidative decarboxylation of
6-phosphogluconate to ribulose 5-phosphate and CO2, with concomitant reduction of NADP to NADPH (2). Together with glucose-6-phosphate dehydrogenase (G6PD), these enzymes ensure the reducing environment of the cell cytoplasm (3). However, the activities of both enzymes are strongly inhibited by NADPH. It is not quite clear how the enzymes are regulated to maintain the level of reducing power inside cells (4). Deficiency of PGD is generally asymptomatic, and the inheritance of this disorder is autosomal dominant. Hemolysis results from combined deficiency of PGD and 6-phosphogluconolactonase suggest a synergism of the two enzymopathies (5).

References

  1. Barcia-Vieitez, R. and Ramos-Martinez, J.I. (2114) IUBMB Life 66:775.
  2. Wamelink, M.M. et al. (2008) J. Inherit. Metab. Dis. 31:703.
  3. Tsui, S.K.W. et al. (1996) Biochem. Genet. 34:367.
  4. Zimmer, H.G. (1996) Mol. Cell Biochem. 160-161:101.
  5. Caprari, P. et al. (2001) Ann. Hematol. 80:41.

Long Name

6-Phosphogluconate Dehydrogenase

Alternate Names

6PGD, PGDH

Entrez Gene IDs

5226 (Human); 110208 (Mouse); 362660 (Rat)

Gene Symbol

PGD

UniProt

Additional 6-Phosphogluconate Dehydrogenase/PGD Products

Product Documents for Recombinant Human 6-Phosphogluconate Dehydrogenase/PGD, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human 6-Phosphogluconate Dehydrogenase/PGD, CF

For research use only

Loading...
Loading...
Loading...